Study of TIGR® Matrix in breast reconstruction after mastectomy
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how a special mesh called TIGR® Matrix affects quality of life, safety, and effectiveness after breast reconstruction surgery. It is for women who need or choose to have their breasts removed and reconstructed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman having breast removal surgery (mastectomy) to treat or prevent breast cancer
- Your doctor has already decided to use the TIGR® Matrix mesh in your surgery
- You are generally healthy enough for surgery (ECOG score 0, 1, or 2)
- You are 18 years or older
- You are not pregnant or breastfeeding
- You do not have advanced breast cancer that has spread beyond the breast
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure and manage fluid drainage during immediate breast reconstruction with implants. It may help surgeons reduce complications and improve the reconstruction experience after mastectomy.
This first-time-in-humans study tests a tissue-engineering chamber called MATTISSE® to help the healing of breast reconstruction using specific tissue flaps after mastectomy for cancer. If you qualify, you would be assessed for safety and how well the reconstructed tissue heals.
This study tests a new supportive mesh called ARTIA for women having breast reconstruction immediately after a mastectomy. The mesh is placed under the skin to help hold a breast implant in position during a two-stage reconstruction process.
This trial tests a special supportive material called acellular dermal matrix in women having two-stage breast reconstruction after mastectomy. The goal is to learn how well it works when the implant is placed directly under the skin, over the chest muscle.
This trial tests a new mesh-like device called Melodi Matrix to support breast reconstruction after mastectomy. It may help women who are planning immediate two-stage implant reconstruction after removing one or both breasts.
This study tests if a special mesh called an acellular dermal matrix (SC DERM® Recon) is safe for women having breast reconstruction with implants after mastectomy for breast cancer. It involves careful follow-up to check for any problems.
Hear when a new Implant Based Breast Reconstruction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.